Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors.

× No keyword cloud information.

6 in total

1. Association of Dipeptidyl Peptidase 4 Inhibitor Use With Risk of Bullous Pemphigoid in Patients With Diabetes.

Authors: Seon Gu Lee; Hee Jung Lee; Moon Soo Yoon; Dong Hyun Kim
Journal: JAMA Dermatol Date: 2019-02-01 Impact factor: 10.282

2. Methylprednisolone Plus Low-Dose Methotrexate for Bullous Pemphigoid-A Single Center Retrospective Analysis.

Authors: Agoritsa Gravani; Georgios Gaitanis; Panagiota Spyridonos; Ioannis Alexis; Stelios Tigas; Ioannis D Bassukas
Journal: J Clin Med Date: 2022-06-02 Impact factor: 4.964

3. Clinical, Laboratory and Histological Features of Dipeptidyl Peptidase-4 Inhibitor Related Noninflammatory Bullous Pemphigoid.

Authors: Ágnes Kinyó; Anita Hanyecz; Zsuzsanna Lengyel; Dalma Várszegi; Péter Oláh; Csaba Gyömörei; Endre Kálmán; Tímea Berki; Rolland Gyulai
Journal: J Clin Med Date: 2021-04-28 Impact factor: 4.241

Review 4. The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations.

Authors: Khalaf Kridin; Ralf J Ludwig
Journal: Front Med (Lausanne) Date: 2018-08-20

5. Case Report: Appearance of Various Disease-Specific Antibodies After the Onset of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.

Authors: Yuichiro Iwamoto; Takatoshi Anno; Katsumasa Koyama; Fumiko Kawasaki; Kohei Kaku; Koichi Tomoda; Seiko Sugiyama; Yumi Aoyama; Hideaki Kaneto
Journal: Front Immunol Date: 2022-03-03 Impact factor: 7.561

6. Co-medications and dipeptidyl peptidase-4 inhibitors associated bullous pemphigoid.

Authors: Agoritsa Gravani; Panagiota Christou; Stelios Tigas; Ioannis D Bassukas
Journal: An Bras Dermatol Date: 2021-09-30 Impact factor: 1.896

6 in total